These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 22720992

  • 21. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
    Boswood A, Gordon SG, Häggström J, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2018 Jan; 32(1):72-85. PubMed ID: 29214723
    [Abstract] [Full Text] [Related]

  • 22. Use of pimobendan in feline congenital heart failure.
    Wainberg S.
    Can Vet J; 2013 Dec; 54(12):1164-6. PubMed ID: 24293678
    [Abstract] [Full Text] [Related]

  • 23. Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure.
    Kawano H, Arakawa S, Satoh O, Matsumoto Y, Hayano M, Nakatomi D, Yamasa T, Maemura K.
    Geriatr Gerontol Int; 2014 Jan; 14(1):109-14. PubMed ID: 23581555
    [Abstract] [Full Text] [Related]

  • 24. [Pimobendan (UDCG 115 BS) in long-term therapy of chronic heart failure].
    Bergler-Klein J, Globits S, Stefenelli T, Mayr H, Porenta G, Sochor H, Glogar D.
    Z Kardiol; 1992 Oct; 81(10):546-52. PubMed ID: 1441695
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
    Pouleur H, Hanet C, Schröder E, Col J, Van Mechelen H, Etienne J, Rousseau MF.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 2():S18-22. PubMed ID: 2478787
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy of pimobendan in the prevention of congestive heart failure or sudden death in Doberman Pinschers with preclinical dilated cardiomyopathy (the PROTECT Study).
    Summerfield NJ, Boswood A, O'Grady MR, Gordon SG, Dukes-McEwan J, Oyama MA, Smith S, Patteson M, French AT, Culshaw GJ, Braz-Ruivo L, Estrada A, O'Sullivan ML, Loureiro J, Willis R, Watson P.
    J Vet Intern Med; 2012 Oct; 26(6):1337-49. PubMed ID: 23078651
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Hemodynamic profile of the cardiotonic agent pimobendan.
    van Meel JC, Diederen W.
    J Cardiovasc Pharmacol; 1989 Oct; 14 Suppl 2():S1-6. PubMed ID: 2478784
    [Abstract] [Full Text] [Related]

  • 34. Effects of furosemide and the combination of furosemide and the labeled dosage of pimobendan on the circulating renin-angiotensin-aldosterone system in clinically normal dogs.
    Lantis AC, Atkins CE, DeFrancesco TC, Keene BW, Werre SR.
    Am J Vet Res; 2011 Dec; 72(12):1646-51. PubMed ID: 22126693
    [Abstract] [Full Text] [Related]

  • 35. A double-blind, randomized, placebo-controlled study of pimobendan in dogs with dilated cardiomyopathy.
    Fuentes VL, Corcoran B, French A, Schober KE, Kleemann R, Justus C.
    J Vet Intern Med; 2002 Dec; 16(3):255-61. PubMed ID: 12041654
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study).
    Effects of Pimobendan on Chronic Heart Failure Study (EPOCH Study).
    Circ J; 2002 Feb; 66(2):149-57. PubMed ID: 11999639
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.